Most cellular RNA species are synthesized as precursors, which are processed to yield mature RNA molecules. Those regions of the pre-RNA not found in the final molecule have to be degraded to avoid accumulation of unwanted RNA species. The turnover of RNA species, in particular mRNA, is important in determining the levels and regulation of gene expression (for review see [@B49], [@B50]; [@B8]). Furthermore, the spatial distribution of certain proteins is achieved by localized control of mRNA stability (St. Johnston, 1995). Whereas specific *cis*- and *trans*-acting factors are required for the regulated decay of specific mRNAs ([@B7]), a more general pathway for the degradation of unwanted RNA is likely to exist into which different RNA species are funneled. Seminal work (for review see [@B5]; [@B8]) in the yeast *Saccharomyces cerevisiae* has identified deadenylation-dependent and -independent decay of mRNA, which requires several enzymatic activities including decapping, endoribonuclease, poly(A) nuclease, and 3′--5′ and 5′--3′ exoribonuclease.

Xrn1p (for review see [@B33]; [@B22]) and Rat1p (also known as Tap1p, Hke1p, Exonuclease 2; for review see [@B58]) are 5′--3′ exonucleases from *S. cerevisiae.* These two enzymes are the only examples of purified 5′--3′ exonucleases in RNA turnover in pro- and eukaryotes (for review see [@B58]) and share substantial sequence homology (see Fig. [2](#F2){ref-type="fig"}), yet both enzymes have functionally diverged. A primarily nuclear role for Rat1p has been suggested ([@B1]; [@B34]; [@B24]), whereas Xrn1p acts and is localized in the cytoplasm ([@B26]; [@B24]; [@B45]; [@B46]; [@B23]).

Xrn1p has been suggested to be the major 5′--3′ exoribonuclease in cytoplasmic mRNA turnover ([@B56], [@B57]) and is active in deadenylation-dependent and -independent pathways ([@B8]). The analysis of *XRN1* mutants suggested a role in RNA turnover of pre-rRNA ([@B59]; [@B24]) and mRNA (for review see [@B5]; [@B8]; [@B28]). In addition to molecular defects in RNA metabolism, the mutants exhibit pleiotropic phenotypes including slow growth, meiotic arrest, and defects in microtubule-related processes (for review see [@B22]). Therefore, it is not surprising that this gene has been isolated in several different screens. Xrn1p ([@B41]) is also known as Sep1p ([@B38]; [@B67]), Stpβp ([@B15], 1991), Kem1p ([@B35]), Rar5p ([@B37]), and Ski1p (for review see [@B71]). It is unclear whether all mutant phenotypes are the consequence of the RNA metabolism defects.

Here we report the first isolation of mammalian cDNAs demonstrated to encode an exoribonuclease active in RNA turnover. mXRN1p is the structural and functional mouse homolog of the *S. cerevisiae* Xrn1p exoribonuclease. Therefore, it is likely to be involved in mRNA turnover and rRNA processing in mouse cells. mXRN1p localizes to cytoplasmic granules and is enriched in prominent foci. The purified mouse protein exhibits 5′--3′ exoribonuclease activity and a substrate preference for RNA G4 tetraplex-- containing substrates in binding and hydrolysis over a monomeric RNA substrate of the same sequence. This specificity was not previously identified for *S. cerevisiae* Xrn1p. The mXRN1p exonuclease activity preferred RNA substrates over DNA substrates, either G4 or monomeric. This suggests that RNA G4 tetraplex structures may occur in vivo, possibly with a role in RNA turnover.

Materials and Methods
=====================

Media and Genetic Methods
-------------------------

The methods used for growing and constructing *S. cerevisiae* strains ([@B53]) and media for *S. cerevisiae* ([@B53]; [@B2]) have been described. To test sensitivity to benomyl, *S. cerevisiae* cultures were grown in SD-ura medium, and the titer was adjusted to 2 × 10^7^ cells/ml. 3 μl of cells from serial 10-fold dilutions were spotted on plates containing 0 or 15 μg/ml benomyl. Plates were incubated for 2 d at 30°C and photographed.

S. cerevisiae Strains
---------------------

The *S. cerevisiae* strain WDHY131 (*MATa ura3-52 trp1 leu2Δ1 his3Δ200 pep4::HIS3 prb1-Δ1.6R can1^R^ xrn1Δ::LEU2*) has been described ([@B4]). For the meiosis experiment we used *S. cerevisiae* strains that are isogenic derivatives of the wild-type isolate *S. cerevisiae* SK-1 ([@B31]). The parent strain derives from a single spore, and marker systems have been developed in N. Kleckner\'s laboratory (Harvard University, Cambridge, MA), who kindly supplied basic strains. These strains show efficient and fast sporulation (see Table [I](#TI){ref-type="table"}). WDHY187 (*MATa/MATα ho::LYS2/ho::LYS2 lys2/lys2 ura3/ura3 leu2::hisG/leu2:: hisG his4B/his4X XRN1/xrn1Δ*::*URA3*), WDHY213 (*MATa/MATα ho:: LYS2/ho::LYS2 lys2/lys2 ura3/ura3 leu2::hisG/leu2::hisG his4B/his4X can1^R^*/*CAN1 xrn1Δ::URA3/xrn1Δ::LEU2*), and WDHY344 (*MATa/MATα ho::LYS2/ho::LYS2 lys2/lys2 ura3/ura3 leu2::hisG/leu2::hisG his4B/his4X can1^R^*/*CAN1 xrn1Δ::ura3/xrn1Δ::LEU2*) were constructed for this study. A spontaneous mutation inactivating the *URA3* gene disrupting *XRN1* in WDHY344 was isolated on medium containing 5-fluoro-orotic acid.

Plasmids
--------

The complementation plasmids are based on the *S. cerevisiae CEN-ARS* plasmid YCp50 (see [@B4]). p*XRN1* (pWDH276) was derived from pJI82 ([@B35]) containing a chromosomal fragment of the *XRN1* region by deletion of a vector SalI site and engineering a SalI site just upstream from the ATG of the *XRN1* open reading frame for efficient further recloning. p*mXrn1* (pWDH347) and p*mXrn1Δ39* (pWDH348) were derived from p*XRN1* by substituting the *XRN1* open reading frame with the full-length mouse cDNAs using the promoter SalI site and the vector HindIII site. pGAL*XRN1* is pRDK249 ([@B29]) in which the *XRN1* open reading frame is expressed under the control of the *GAL10* promoter. The mouse full-length cDNAs were cloned in pRDK249, replacing the resident *XRN1* open reading frame and resulting in pGAL*mXrn1* (=pWDH349) and pGAL*mXrn1Δ39* (=pWDH350). Vector control pGAL (=pWDH181) contains no open reading frame under the control of the *GAL10* promoter of pRDK249.

Cloning of Mouse mXrn1
----------------------

For PCR amplification, two oligonucleotides ending with EcoRI recognition sequences at their 5′ ends (5′-GGAATTCCI(C/A)GIGCIAA(A/G) ATGAA(C/T)CA(A/G)CA-3′ and 5′-GGAATTCATIAG(G/A)TCIGC(G/ A)T CIAGICC(G/A)TA-3′, where I refers to inosine) were synthesized. These sequences correspond to highly conserved regions of *S. cerevisiae XRN1* ([@B35]) and *Schizosaccharomyces pombe Exo2* ([@B63], [@B64]), as well as *S. cerevisiae RAT1* ([@B1]). The amino acid sequence encoded by the first oligonucleotide (PRAKMNQQ) corresponds to amino acid residues 90--97, and the sequence encoded by the second oligonucleotide (YGLDADLI) corresponds to residues 203--210 of the *S. cerevisiae* Xrn1 protein. PCR was performed with 5 ng of mouse testis cDNA as a template for 30 cycles of 5 s at 94°C, 15 s at 37°C, and 2 min at 72°C. The PCR products were analyzed on a 4% agarose gel (NuSieve^®^; FMC BioProducts, Rockland, ME), eluted from the gel, and subcloned in M13mp19 for sequence analysis. A 363-bp PCR product was used as a probe for the first round screening of a mouse testis cDNA bank. Recombinant phages λ511, λ14, and λ1620 were isolated from a mouse testis cDNA library in λgt10 (BALB/c; Clontech, Palo Alto, CA), λ2100 from a mouse testis cDNA library in λgt11 (BALB/C; Clontech), and λ10, λ1, λ6, λ4, λ9, and λ3 from a mouse thymus cDNA library in λZAP (B6/CBAF1J; Stratagene Inc., La Jolla, CA) using the probes indicated in Fig. [1](#F1){ref-type="fig"} *A.* All cDNA clones displayed in Fig. [1](#F1){ref-type="fig"} were sequenced on both strands. Full-length cDNA constructs were reconstructed by joining inserts from λ511 and λ10 at their unique HpaI sites for p*mXRN1* and joining inserts from λ511 and λ1 for p*mXrn1Δ39.* Standard procedures were used for DNA library screening, DNA hybridization, and sequencing. These sequence data are available from EMBL/GenBank/DDBJ under accession number X91617.

Purification of Mouse mXRN1p
----------------------------

*S. cerevisiae* strain WDHY131 (*xrn1Δ*) bearing plasmid pGAL*mXrn1* was induced by galactose for overproduction of mouse mXRN1p as described ([@B29]). After harvesting and washing in 20 mM Tris-HCl, pH 7.5, 300 mM NaCl, 1 mM EDTA, and 1 mM PMSF, the cells were frozen in liquid nitrogen and stored at −70°C. 24 g of cells was thawed on ice. All the steps were performed at 4°C. mXRN1p purification was monitored by Western blot with a rabbit polyclonal anti-mXRN1p antibody. The cell slurry was diluted to 1.25 ml of buffer A containing 300 mM NaCl per gram of cells. Buffer A is 20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 10% (wt/vol) glycerol, 10 mM β-mercaptoethanol, 0.2 mM PMSF, 2 mM benzamidine, 2 μM pepstatin A, and 2 μM leupeptin. Cells were disrupted in a bead beater (Biospec Products, Bartlesville, OK) with six 30-s pulses with 2 min of cooling between pulses. The glass beads were washed twice with 10 ml buffer A/300 mM NaCl. Cell lysate and wash were combined and centrifuged in a Ti45 rotor (45 min, 40 krpm at 4°C) resulting in fraction I (15.7 mg/ml, 75 ml). Fraction I was loaded on a phosphocellulose column (P11; Whatman Inc., Clifton, NJ) equilibrated with buffer A/300 mM NaCl at a flow rate of 70 ml/h. The flowthrough was collected as fraction II (100 ml, 10 mg/ml) and centrifuged at 8 krpm for 20 min to collect the precipitate. The supernatant (fraction III, 4 mg/ml) was reapplied on a new P11 column preequilibrated in buffer A/300 mM NaCl. After washing with buffer A/300 mM NaCl, proteins were eluted with 150 ml of buffer A/1 M NaCl. The eluting fractions containing mXRN1p were pooled (35 ml) and concentrated on an ultra filtration unit (Centriprep100; Amicon, Beverly, MA) to result in fraction IV (0.9 mg/ml, 3.5 ml). The conductivity of fraction IV was adjusted to 1 M NaCl and loaded on a gel filtration column (Sephacryl S-200; Pharmacia, Piscataway, NJ; 2 cm^2^ × 70 cm) at a flow rate of 19 ml/h. mXRN1p-containing fractions were dialyzed against buffer B containing 20 mM Tris-HCl, pH 7.5, 0.1 mM EDTA, 1.0 mM DTT, 500 mM NaCl, and 60% (wt/vol) glycerol and stored at −20°C (fraction V; 0.02 mg/ml, 0.32 ml). All experiments were performed using fraction V.

Protein Methods and Antibodies
------------------------------

Glass bead extracts of total *S. cerevisiae* protein were done as described ([@B29]). Protein extracts and fractionation from adult mouse testis cells was performed as described ([@B14]). Proteins were separated on 8% SDS-PAGE and either stained with Coomassie brilliant blue or analyzed by Western blotting. As first antibodies, we used affinity-purified rabbit anti-mXRN1p antibodies (0.2 μg/ml) or the Ig fraction of rat anti-mXRN1p antibodies (1:5,000 dilution), which recognize mouse mXRN1p but not *S. cerevisiae* Xrn1p. Signals were detected using HRP-conjugated anti--rabbit or anti--rat IgG antibodies (1: 4,000 or 1:7,500 dilution, respectively) as secondary antibodies in the ECL system (Amersham Corp., Arlington Heights, IL) according to manufacturer\'s instructions. To visualize the *S. cerevisiae* Xrn1p on the same blot, the anti--*S. cerevisiae* Xrn1p mouse mAb H8 ([@B23]) (1 μg/ml) was used after detecting mouse mXRN1p. Xrn1p signals were generated using HRP-conjugated rabbit anti--mouse Ig antibodies (1:4,000 dilution; ECL system; Amersham Corp.).

The anti--mouse mXRN1p antibodies were generated against a His(6) fusion to amino acids 1,132--1,719 of mXRN1p, which was overexpressed in *Escherichia coli* using the pT7-7 system ([@B65]). The protein was purified by Ni^++^ chelate affinity chromatography (Qiagen, Inc., Chatsworth, CA) according to the manufacturer\'s instructions followed by preparative SDS-PAGE and electroelution of the protein band from the gel slice. 400 and 100 μg of purified antigen were injected into rabbits or rats, respectively, and the immune response was boosted three times. Antibodies were affinity purified from serum on His(6)--mXRN1p(aa 1,132--1,719) containing nitrocellulose strips as described ([@B48]).

Biochemical Methods
-------------------

Exoribonuclease activity was assayed essentially as described ([@B56], [@B57]; [@B32]). 3.72 pmol (2.6 × 10^4^ cpm/pmol) of \[^32^P\]GTP-labeled T7 in vitro transcript of 367 nt mouse β-actin was used as a substrate in reactions containing 100 fmol of mXRN1p.

G4 tetraplex DNA or RNA was prepared from deoxy-oligonucleotide (5′-TATGGGGGAGCTGGGGAAGGTGGGATTT-3′; called GL) or the same sequence of ribo-oligonucleotide (rGL) and 5′ end-labeled with T4 polynucleotide kinase using \[γ-^32^P\]ATP essentially as described ([@B18]). For binding assays (20 μl), 0.3 fmol of 5′ ^32^P-labeled tetraplex RNA (rGL\[G4\]), tetraplex DNA (GL\[G4\]), or single-stranded oligo (rGL\[SS\]) were incubated with 0.05--200 fmol protein at 4°C for 20 min in binding buffer (20 mM Hepes, pH 7.5, 100 mM KCl, 10% glycerol, 1 pmol unlabeled oligonucleotide TP-S 5′-TGGACCAGACCTAGCA3′, and 1 μg poly \[dI-dC\]: poly\[dI-dC\]) and run on 6% polyacrylamide gel ([@B52]; [@B42]). The dried gels were quantified using a PhosphorImager. For nuclease assays, 20 fmol of the GL(G4), rGL(G4), GL(SS), and rGL(SS) substrates and 2.5 fmol of mXRN1p unless otherwise specified were used in binding buffer supplemented with 3 mM MgCl~2~ without the unlabeled TP-S oligonucleotide. The reaction was carried out at 37°C. The extent of hydrolysis was determined by quantification of the dinucleotide first cleavage product on a PhosphorImager expressed as fmol of cleaved substrate.

mXRN1p was immunoprecipitated from fraction V using magnetic beads coated with sheep anti--mouse IgG~1~ (Fc) (30 mg/ml; Dynabeads M-450; Dynal Inc., Great Neck, NY) coupled to 20 μg of the anti-Xrn1p mAbs H8 or B4 (Holler et al., 1994) by overnight rocking at 4°C in 500 μl PBS (0.15 M NaCl and 0.01 Na-phosphate, pH 7.4) containing 0.1% BSA. Both anti-Xrn1p mAbs are of the IgG~1~ subtype; mAb-H8 recognizes both *S. cerevisiae* Xrn1p and mouse mXRN1p, whereas mAb-B4 is specific for the *S. cerevisiae* Xrn1 protein. After coupling, the beads were washed three times in PBS containing BSA and once in PBS containing BSA, 0.5 M NaCl, and 5% (wt/vol) glycerol. Each sample of Dynabeads loaded with primary and secondary antibodies, or only with primary antibody (control), was divided on two parts and separately incubated with 40 ng of mXRN1p (fraction V) in 500 μl of PBS containing BSA, 0.5 M NaCl, and 5% (wt/vol) glycerol for 12 h at 4°C. After washing the Dynabeads four times in the same buffer and once in 10 mM Tris-HCl, pH 8.8, the binding between primary and secondary antibodies was broken by treatment with 25 μl of freshly prepared 100 mM triethylamine, pH 11.5, for 10 min at 4°C. The immunoprecipitate was neutralized with 2 μl of 1 M Tris-HCl, pH 7.5. 5 μl of the immunoprecipitate was used for the binding reaction with ^32^P-labeled G4 DNA as substrate, and another 5 μl was used for immunoblotting for detection of mXrn1p. Under these conditions the exonuclease function of mXRN1p lost its activity (data not shown).

Immunofluorescence Methods
--------------------------

Cells were grown in DME (Life Technologies, Gaithersburg, MD) and 15% FCS on clean glass slides to 80% confluence. Benomyl was added to the culture medium at 40 μg/ml for 5 h, while cold-treated cells were kept at 4°C for 10 h. The efficacy of the drug treatment or the cold treatment was demonstrated by the reduced immunofluorescence using anti-tubulin antibodies (see Fig. [9](#F9){ref-type="fig"}). Cells were washed in PBS and fixed for 10 min in 4% formaldehyde, 0.02% glutaraldehyde, and 0.2% Triton X-100/PBS. After subsequent washing, cells were simultaneously immunostained ([@B20]) with rat anti--tubulin antibodies (Serotec Ltd., Oxford, UK; second antibody was an FITC conjugate, Sigma Chemical Co., St. Louis, MO) and rabbit anti--mouse mXRN1p antibodies (second antibody was a Cy3 conjugate, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Immunostaining of the actin cytoskeleton was performed with coumarin--phaloidin (Sigma Chemical Co.). Antibodies against vimentin were kindly provided by G. Giese (MPI Cell Biology, Ladenburg, Germany). The anti-mXRN1p antibodies used for immunofluorescence were the same affinity-purified antibodies used in Western blot analysis (see Fig. [6](#F6){ref-type="fig"}). Fig. [6](#F6){ref-type="fig"} demonstrates their specificity for mXRN1p. Finally, preparations were embedded in antifade solution (Vector Laboratories, Inc., Burlingame, CA) and analyzed using a fluorescence microscope (Axioskop; Carl Zeiss, Inc., Thornwood, NY) equipped with single-band pass filters for excitation of red, green, and blue fluorescence (Chroma Technologies Corp., Brattleboro, VT). Images of high magnification and resolution were obtained using a black and white CCD camera controlled by ISIS fluorescence image analysis software (METASystems, Altlussheim, Germany). The number of foci was counted in 50 cells using a size cutoff of 300 nm; given are mean numbers ± 1 SD. The diameter of foci was determined in at least 27 foci from two independent experiments; given is the mean diameter ± 1 SD. Measurements were performed on digitized and enhanced images using the measurement option of the ISIS fluorescence image analysis software package.

Computer Analysis
-----------------

Homologies of mXRN1p to other proteins were detected in a FASTA search. The sequences were aligned, and the phylogenetic tree was generated with the Growtree program using the Kimura protein distance algorithm. The identity between individual homology boxes was scored in GAP alignments (gap weight = 3, length weight = 0.1). The sequences were *S. cerevisiae* Xrn1p ([@B35]) and Rat1p ([@B1]), *S. pombe* Dhp1p ([@B61]), ExoIIp ([@B64]), and mouse Dhm1p ([@B54]). All programs were implemented in the GCG software package (version 8.0; Genetics Computer Group, Inc., Madison, WI) ([@B13]).

Results
=======

Mouse cDNAs Encoding an Exoribonuclease
---------------------------------------

Mouse cDNAs deriving from the mammalian homolog of *S. cerevisiae XRN1* (Fig. [1](#F1){ref-type="fig"}) have been identified by a PCRbased approach. A full-length cDNA of 5,497 nt was assembled, and an RNA consistent with this predicted size was detected in Northern blots of RNA isolated from mouse tissues (data not shown). Two cDNA variants were recovered, *mXrn1* and *mXrn1Δ39. mXrn1Δ39* carried an in-frame 39-bp deletion leading to a predicted protein product smaller by 13 amino acids (Fig. [1](#F1){ref-type="fig"}). PCR analysis of genomic DNA and cDNA derived from testis suggests that both cDNAs represent splice variants of a single-copy gene and that the deleted sequence in *mXrn1Δ39* corresponds to an optional exon (data not shown). The DNA sequence (accession number X91617, not shown) predicts a 5,157-bp open reading frame for *mXrn1* with a coding potential for a 194.2-kD protein composed of 1,719 amino acid residues and, for *mXrn1Δ39*, a 5,118-bp open reading frame potentially encoding a 192.9-kD protein. The putative initiation codon for both cDNAs is located in a region with highly significant homology to the NH~2~-terminal region of the homologous genes ([@B35]; [@B1]) (see Fig. [2](#F2){ref-type="fig"} *A*). In addition, the sequence around this ATG initiation codon (AAA[ATG]{.ul}GGA) fits well to the consensus proposed by [@B39] with a purine and a guanosine at positions −3 and +4, respectively. Given the additional fact that the cDNAs exhibit biological activity (Figs. [3](#F3){ref-type="fig"}--[5](#F5){ref-type="fig"} and below), we conclude that the indicated ATG is highly likely to be the start codon of the *mXrn1* gene. The 3′ end of both cDNAs is characterized by a relatively short oligo(A) tail of between 8 and 22 residues in six different clones (Fig. [1](#F1){ref-type="fig"}). Short poly(A) tails have been suggested to be of importance for the regulation of expression of several eukaryotic genes ([@B3]).

Database searches revealed homologies to the protein sequences of the genes used for the PCR cloning strategy (see Materials and Methods), *S. cerevisiae XRN1* and *S. pombe exo2*, and to a group of related proteins and predicted proteins from *S. cerevisiae*, *S. pombe*, and mouse (Fig. [2](#F2){ref-type="fig"}). No other significant homologies were identified. The phylogenetic relationship between the individual sequences (Fig. [2](#F2){ref-type="fig"} *B*) suggests the existence of two subfamilies of related proteins with demonstrated or suspected exonuclease activity. In both subfamilies, the two yeast sequences show a slightly closer relationship to each other than to the mouse sequence.

Mouse mXRN1p Is Functional in S. cerevisiae
-------------------------------------------

The sequence data suggested that the mouse cDNAs derive from a homolog of the yeast genes, and we sought functional evidence to support this notion. To this end, we constructed plasmids placing the two mouse cDNA variants under the control of the cognate *S. cerevisiae XRN1* promoter to yield p*mXrn1* and p*mXrn1Δ39* for the long and short variants, respectively. These plasmids together with the equivalent *S. cerevisiae* construct (p*XRN1*) were used to assay for complementation of defects caused by a deletion of the *XRN1* gene in *S. cerevisiae* (see Figs. [3](#F3){ref-type="fig"}--[5](#F5){ref-type="fig"}).

*xrn1Δ* cells exhibit pleiotropic phenotypes caused by defects in RNA turnover (for review see [@B58]; [@B8]) and in the cytoskeleton ([@B35]; [@B27]). Both mouse cDNAs complemented the slow-growth phenotype almost as efficiently as the cognate plasmid--borne gene (doubling times: vector control, 209 min; p*XRN1*, 148 min; p*mXrn1*, 166 min; p*mXrn1Δ39*, 170 min; see also Fig. [3](#F3){ref-type="fig"} for a semiquantitative test). Moreover, the benomyl hypersensitivity of the *S. cerevisiae* mutant was also complemented to a large extent, but not as efficiently as by the *S. cerevisiae XRN1* gene (Fig. [3](#F3){ref-type="fig"}).

A striking phenotype of *xrn1Δ* cells is a quantitative meiotic prophase arrest in pachytene leading to highly reduced sporulation (Table [I](#TI){ref-type="table"}) ([@B2]; [@B68]). This phenotype is complemented by both mouse cDNAs essentially to the same extent as by the *S. cerevisiae* gene (Table [I](#TI){ref-type="table"}).

One RNA turnover defect in *xrn1Δ* cells is the accumulation of a fragment of the internal transcribed spacer of pre-rRNA, which is usually degraded during cytoplasmic processing of the 20S precursor to the 18S RNA ([@B59]) (Fig. [4](#F4){ref-type="fig"} *A*). The accumulation of this fragment can be visualized by Northern blot analysis in total RNA of *xrn1Δ* cells (Fig. [4](#F4){ref-type="fig"} *B*, lane *1*) but not in *xrn1Δ* cells containing the wild-type gene on a plasmid (lane *2*). Both mouse cDNAs complemented this molecular defect of the *S. cerevisiae* mutant to the same extent as the cognate gene (lanes *3* and *4*).

mRNA turnover defects in *xrn1Δ* cells are signaled, for example, by the accumulation of certain mRNAs as poly(A)^−^ species ([@B26]). A large *XRN1*dependent effect can be observed for the *RP51A* mRNA, whereas only a small effect can be documented for *ACT1* mRNA (Fig. [5](#F5){ref-type="fig"}), consistent with previous observations ([@B26]). Both defects can be complemented by the cognate wild-type gene or by both mouse cDNAs, essentially to the same extent (Fig. [5](#F5){ref-type="fig"}).

Purification and Characterization of mXrn1p
-------------------------------------------

The open reading frame discovered in the mouse cDNA predicted a protein of 194 kD, and a polypeptide of this size can be visualized by immunoblot analysis in *S. cerevisiae* cells overexpressing the cDNAs from the regulated *GAL10* promoter (Fig. [6](#F6){ref-type="fig"} *A*, lanes *3* and *4*). Moreover, a polypeptide of identical size can be detected in cytoplasmic protein extracts from mouse testis (lane *5*). This demonstrates that the mouse gene from which we derived the cDNAs encodes the predicted protein in vivo. No immunoreactive bands of this size were detected in high salt extracts of nuclei (data not shown), consistent with the localization of the protein in the cytoplasm (see below). In addition, this analysis demonstrated the specificity of the anti-mXRN1p antibodies because they recognize only the mXRN1p band in protein extracts from mouse testis (Fig. [6](#F6){ref-type="fig"} *A*) and other tissues as well as from mouse E10 cells (data not shown). To obtain direct biochemical evidence that mouse mXRN1p exhibits exoribonuclease activity, we purified the protein (Fig. [6](#F6){ref-type="fig"} *B*) and demonstrated in vitro exoribonuclease activity (Fig. [7](#F7){ref-type="fig"} *A*). Because both mouse cDNA variants (*mXrn1* and *mXrn1Δ39*) were found to have identical biological activity in all interspecies complementation assays (Figs. [3](#F3){ref-type="fig"}--[5](#F5){ref-type="fig"}), we decided to purify and characterize only the longer version of mouse mXRN1p.

A nuclear role for Xrn1p has been proposed based on the specificity of the enzyme for G4 tetraplex--containing DNA substrates ([@B42]; [@B43]). mXRN1p exhibited a substrate binding specificity for G4 tetraplex--containing DNA and RNA substrates (Fig. [7](#F7){ref-type="fig"} *B*). In these experiments (Fig. [7](#F7){ref-type="fig"}, *B--D*) we used the same sequence oligonucleotides either as RNA (rGL) or as DNA (GL) in their monomeric form (rGL\[ss\], GL\[ss\]) or in their G4 tetraplex form (rGL\[G4\], GL\[G4\]) after forming the tetraplex in vitro and purifying the tetraplex substrate as described in Materials and Methods. In binding experiments, the equilibrium constants derived from Scatchard analysis of the data shown in Fig. [7](#F7){ref-type="fig"} *B* showed a higher affinity of mXRN1p for the G4 RNA substrate (K~eq~ = 2.95 ± 0.32 × 10^10^ M^−1^) than for the G4 DNA substrate (K~eq~ = 1.26 ± 0.24 × 10^10^ M^−1^) or the monomeric RNA oligonucleotide of the same sequence (K~eq~ = 2.57 ± 0.34 × 10^9^ M^−1^). These differences are small but significant, as indicated by the nonoverlapping standard deviations. Kinetic analysis of the exonuclease activity using G4 tetraplex and monomeric RNA as well as DNA substrates revealed more striking differences (Fig. [7](#F7){ref-type="fig"} *C*). mXRN1p hydrolyzed the first cleavage in the RNA substrates (G4 tetraplex and monomeric) with a biphasic kinetics, exhibiting a fast early and a slower late component. Both DNA substrates were hydrolyzed with a more uniform and significantly slower kinetics than the RNA substrates. In particular, a large difference was apparent between the RNA and DNA G4 tetraplex substrates. During the first reaction phase, hydrolysis of the RNA G4 substrate was at least 14 times faster than that of G4 DNA (Fig. [7](#F7){ref-type="fig"} *C*). The kinetics data of the hydrolysis also demonstrate a significant preference of mXRN1p for the G4 tetraplex versus monomeric RNA substrate (Fig. [7](#F7){ref-type="fig"} *C*) consistent with the quantitative binding studies (Fig. [7](#F7){ref-type="fig"} *B*).

A protein titration of mXRN1p using G4 tetraplex DNA and RNA substrates is shown in Fig. [7](#F7){ref-type="fig"} *D.* These data visualize again the preference of mXRN1p for RNA substrates. In addition, the gel shows the position of the first cleavage product (*CP* in Fig. [7](#F7){ref-type="fig"} *D*), a radiolabeled two-nucleotide product. This was also shown by further high resolution gel electrophoresis using appropriate standards (data not shown). Because the substrate has been labeled at its 5′ end, this analysis also demonstrates that mXRN1p is a 5′-- 3′ exonuclease.

Several lines of evidence suggest that the exonuclease activity and the substrate specificity for G4 tetraplex substrates is intrinsic to mXRN1p and not due to a minor contaminant. First, the 5′--3′ exonuclease activity of mXRN1p and its enzymatic characteristics is consistent with the biochemical analysis of the homologous enzymes from *S. cerevisiae* ([@B57]; [@B29], [@B30]) and *S. pombe* ([@B63]; [@B32]), which also possess 5′--3′ exonuclease activity. Second, the mouse enzyme has been purified from a *S. cerevisiae* strain deleted for the endogenous *XRN1* gene, which encodes Xrn1p, the major 5′--3′ exonuclease activity in *S. cerevisiae* cells. Third, the amount of protein added in the nuclease experiments (Fig. [7](#F7){ref-type="fig"}, *A* and *C*; see Materials and Methods) was small, working at excess of substrate. Any contaminant would have to be an unusually active nuclease, presently unknown in *S. cerevisiae.* In side-by-side experiments using mXRN1p and *S. cerevisiae* Xrn1p, the mouse enzyme exhibited higher specific activity than the yeast enzyme (Bashkirov, V.I., and W.-D. Heyer, unpublished data). Fourth, the amount of protein added in the binding experiments (Fig. [7](#F7){ref-type="fig"} *B*) was low, showing 50% binding of 0.3 fmol of substrate at only 2.3fold excess of mXRN1p (0.68 fmol as calculated from Fig. [7](#F7){ref-type="fig"} *B*). This quantitatively excludes a minor contaminant being responsible for the G4 tetraplex binding activity. Fifth, an immunoprecipitation experiment (Fig. [8](#F8){ref-type="fig"}) demonstrated that the G4 tetraplex specificity was intrinsic to mXRN1p by an independent method. Using two anti-Xrn1p mAbs, one cross-reacting with mXRN1p (H8) and the other (B4) not cross-reacting with the mouse protein, we demonstrated that only H8, the antibody recognizing the mouse protein, could immunoprecipitate mXRN1p (Fig. [8](#F8){ref-type="fig"} *A*) and that the immunoprecipitate formed a specific complex with G4 tetraplex DNA (Fig. [8](#F8){ref-type="fig"} *B*). Sixth, the observed coupling of the binding and the cleavage reaction on several G4-containing substrates (Fig. [7](#F7){ref-type="fig"}, *B* and *C*, and data not shown) argues that both activities were mediated by one protein. Finally, the temperature optimum of the mXRN1p nuclease activity was determined to be 37°C, typical for a mammalian but atypical for a yeast enzyme. The *S. cerevisiae* Xrn1p nuclease activity showed an optimum at 30°C.

mXRN1p Has Two Types of Localization in Mammalian Cytoplasm
-----------------------------------------------------------

mXRN1p immunostaining revealed a general granular signal and an enrichment in a number of discrete, prominent foci (\>300 nm) in the cytoplasm of mouse E10 cells (Fig. [9](#F9){ref-type="fig"}) and skin fibroblast cell lines as well as in rat RBL-1 and human HeLa cells (data not shown). We focus here on mouse E10 cells because their large and well-defined cytoplasm allowed more precise definition of the sublocalization. However, essentially the same conclusions are reached from the analysis of the other cell types. The cytoplasmic foci and the general granular staining did not appear with preimmune control antibodies (Fig. [9](#F9){ref-type="fig"}) or with other antibodies against cytoskeletal components including tubulin (Fig. [9](#F9){ref-type="fig"}), actin, and vimentin (data not shown). Double and triple immunofluorescence experiments using antibodies against mXRN1p and against cytoskeletal components concomitantly demonstrated at the light microscopic level the general absence of tubulin, actin, or vimentin from the mXRN1p containing foci (data not shown). This is consistent with the immunofluorescence data shown in Fig. [9](#F9){ref-type="fig"}. In mouse E10 cells, an average of 10.5 ± 4.1 mXRN1p-containing foci were detected per cell, with an average diameter of 570 ± 113 nm. Similar numbers of foci were observed in mouse skin fibroblasts (11.3 ± 8.5) and in HeLa cells (11.1 ± 4.3).

The general granular staining (Fig. [9](#F9){ref-type="fig"}) consists of smaller foci (\<250 nm) resolved at high contrast and resolution only by digital image analysis (data not shown). Addition of benomyl, a drug that inhibits microtubule polymerization and effectively destroys microtubular structures, essentially abolished the cytoplasmic microtubuli network as expected and also the general cytoplasmic localization of mXRN1p but not the localization in foci (Fig. [9](#F9){ref-type="fig"} *d*). Similarly, cold treatment (Fig. [9](#F9){ref-type="fig"} *c*), which is known to destroy microtubular structures, reduced the cytoplasmic microtubular immunofluorescence as well as the general granular cytoplasmic but not the localization in foci of mXRN1p. The similarity between the cytological appearance of mXRN1p staining in Fig. [9](#F9){ref-type="fig"}, *c* and *d*, suggests that the benomyl effect is not a drug-related artifact.

The cytoplasmic localization of mXRN1p in mammalian cells is consistent with the localization of Xrn1p in *S. cerevisiae* ([@B23]), which could not provide the structural details seen here for the small size of the yeast cells. There is no evidence by immunofluorescence or cell fraction studies that Xrn1p in *S. cerevisiae* occurs in the nucleus ([@B23]). Equally, mXRN1p in mouse has only been identified in the cytoplasm of tissue culture cells or in testis tissue preparations by use of immunofluorescence and cell fraction techniques (Fig. [9](#F9){ref-type="fig"}; Scherthan, H., V.I. Bashkirov, and W.-D. Heyer, unpublished data). Although the data presented here show no positive evidence for nuclear localization of mXRN1p, it will be very difficult to totally exclude that small amounts of mXRN1p are present in the nucleus. A detailed study using confocal laser scanning microscopy will help resolve this issue.

Discussion
==========

mXRN1p Is the Mouse Homolog of the Major S. cerevisiae Cytoplasmic Exoribonuclease Xrn1p
----------------------------------------------------------------------------------------

*S. cerevisiae* Xrn1p is likely to be the major cytoplasmic exoribonuclease for RNA turnover of mRNA, the internal transcribed spacer of pre-rRNA, and possibly other RNA species (for review see [@B58]; [@B8]; [@B28]). The conservation of the molecular structure (Fig. [2](#F2){ref-type="fig"}) and the cellular functions (Figs. [3](#F3){ref-type="fig"}--[5](#F5){ref-type="fig"}) gives compelling evidence that mXRN1p of mouse is the Xrn1p homolog of higher eukaryotes. This strongly suggests a similar function for mXRN1p in mouse cells. This is consistent with the evolutionary conservation of the general mRNA structure (cap, poly(A) tail) and of the pre-rRNA structure and processing ([@B17]; [@B69]).

To date, no difference in biological activity of the two mXRN1p variants in mouse (*mXrn1* and *mXrn1Δ39*) has been detected, and the biological significance of the two forms remains unclear. They may have variable distribution and relative abundance in different tissues.

It is presently unclear whether mXRN1p is related to a 5′ exoribonuclease partially purified from cytoplasmic mouse sarcoma cell extracts ([@B11]). However, the hydrolysis products of both activities are somewhat different. mXRN1p and its *S. cerevisiae* homolog, Xrn1p ([@B42]), make a dinucleotide as a first cleavage product and mononucleotides thereafter, whereas the mouse sarcoma activity produces mono-, di-, and trinucleotides ([@B11]). mXRN1p is obviously unrelated to the ∼37-kD 3′--5′ exoribonuclease purified from human cells ([@B9]).

Cellular Roles of Mouse mXRN1p and S. cerevisiae Xrn1p: Nuclear versus Cytoplasmic
----------------------------------------------------------------------------------

Much attention has been given to possible biological functions of G4 tetraplex structures potentially occurring at telomeric DNA ([@B52]; for review see [@B72]). In particular, it was suggested that Xrn1p of *S. cerevisiae* plays a role in nuclear DNA metabolism as an endonuclease acting on G4 tetraplex substrates ([@B42]). However, neither Xrn1p nor mouse mXRN1p are endonucleases, but rather are 5′--3′ exonucleases producing generally mononucleotide products with a first cleavage product of two nucleotides (Fig. [7](#F7){ref-type="fig"} *d*; [@B57]; [@B42]; Bashkirov, V.I., and W.-D. Heyer, unpublished observation).

The mutant phenotypes in *S. cerevisiae* (see Introduction for references) and the in situ localization in yeast ([@B23]) and mouse (Fig. [9](#F9){ref-type="fig"}) suggested a cytoplasmic rather than a nuclear role for the enzymes; therefore, we tested the G4 tetraplex specificity of mouse mXRN1p on RNA and DNA substrates of the same sequence using the corresponding monomeric oligonucleotides as further controls. Previous work on *S. cerevisiae* Xrn1p ([@B42]) was not quantitative and examined G4 DNA substrates but did not analyze RNA substrates. The results of this analysis (Fig. [7](#F7){ref-type="fig"}, *B--D*) clearly showed a high specificity of mXRN1p for RNA over DNA substrates and a strong preference for the G4 RNA substrate versus monomeric substrate. Similar substrate preferences were found with the *S. cerevisiae* Xrn1 protein (Bashkirov, V.I., and W.-D. Heyer, unpublished results).

The pachytene arrest of cells lacking this protein ([@B2]; [@B68]) was interpreted as a result of a role of this protein in nuclear DNA metabolism ([@B42]). Other molecular defects manifest in *xrn1* cells (see Introduction) may also indirectly lead to this meiotic arrest phenotype. Moreover, it is unclear whether G4 tetraplex DNA structures form at all during meiotic prophase. In conclusion, all available evidence regarding in situ localization, substrate specificity, and mutant phenotype in *S. cerevisiae* suggests that these proteins are cytoplasmic in both organisms, consistent with a role in cytoplasmic RNA turnover.

Implications of the Mouse mXRN1p Specificity for G4 RNA Tetraplex Substrates
----------------------------------------------------------------------------

G4 tetraplex structures were first noted in vitro by use of RNA substrates ([@B73]) requiring only as few as four contiguous G residues ([@B10]). They are no less likely to occur in vivo than G4 tetraplex DNA structures ([@B36]). The occurrence of cellular enzymes such as mouse mXRN1p (Fig. [7](#F7){ref-type="fig"}) and Xrn1p (Bashkirov, V.I., and W.-D. Heyer, unpublished observation) with high specificity for G4 tetraplex RNA substrates suggests that these structures may actually occur in vivo. Biochemical evidence suggested G4 tetraplex RNA formation as a mechanism for the dimerization of the HIV-1 genomic RNA ([@B62]). A G-rich region has been implicated in the endonucleolytic cleavage of the human insulin-like growth factor II mRNA ([@B51]). However, the importance of forming a stem--loop structure with a C-rich strand ([@B51]) makes involvement of a G4 tetraplex structure less likely.

If G4 tetraplex RNA occurs in vivo, what could be the functional significance? Given the role of Xrn1p and, by implication, of mXRN1p in RNA turnover, one might speculate on a functional role of this RNA structure in RNA metabolism, specifically RNA turnover. From the enzymological properties of mXRN1p, it is evident that it will bind to G4 tetraplex--containing RNAs with preference because the K~eq~ shows at least a 10-fold difference, and that it will hydrolyze G4 RNA with an initial rate 15 times faster than monomeric RNA. However, the progression of the exonuclease activity is clearly slowed by the G4 tetraplex structure as shown by using 3′-end labeled substrates (Bashkirov, V.I., and W.-D. Heyer, unpublished observation). In vivo, G-rich sequences have been found to stabilize RNA sequences 3′ but not 5′ of the G stretch ([@B70]; [@B12]; [@B47]), consistent with Xrn1p being the relevant 5′--3′ exoribonuclease in RNA turnover. However, G4 tetraplex formation might not be required for this effect because the Xrn1p already pauses at G-rich sites on monomeric (i.e., non-G4) substrates ([@B30]). Addition of a G stretch upstream of the AUG initiation codon greatly destabilized the *PGK* mRNA, reducing the half-life from 35 to 7 min ([@B47]). This effect has not been found for the *MFA2* mRNA or with an insertion of a G-rich sequence downstream of the stop codon in the *PGK* mRNA ([@B12]; [@B46], [@B47]). This differential effect could be explained by the enzymatic properties of Xrn1p/ mXRN1p by suggesting that, in the former case (general destabilization by G stretch insertion), G tetraplex formation occurs. This would attract the nuclease activity to hydrolyze the sequence 5′ to the G4 tetraplex. In the latter case (no general destabilization), no G4 tetraplex formation occurs, leaving the overall half-life of the full-length mRNA unchanged but stabilizing, as in the former case, the sequence 3′ of the G insertion.

It has been proposed that decapping of mRNA is the major control point for mRNA decay ([@B8]). Apparently the only gene encoding such an activity has been identified in *S. cerevisiae*, and strains lacking this activity exhibit a growth impairment ([@B6]), as do *S. cerevisiae xrn1Δ* cells. Besides a control point by a decapping enzyme, a second control point exerted by the *S. cerevisiae* Xrn1p or correspondingly by the mouse mXRN1p exoribonuclease is suggested here. Although Xrn1p has been shown to be more active on decapped RNA, the residual activity on capped RNAs ([@B56]) paired with the G4 specificity provides substance for such a control point. RNA G4 tetraplex formation is a slow process compared with most other nucleic acid annealing processes ([@B62]). Therefore, occurrence of G4 tetraplex structures is correlated to the lifetime of an RNA. A possible model for the role of G4 tetraplex RNA structures is that they attract the degradation of the RNA by Xrn1p/mXRN1p to ensure turnover of an old RNA. mXRN1p itself does not contribute to G4 tetraplex formation because it does not catalyze the formation of this structure (Bashkirov, V.I., and W.-D. Heyer, unpublished observation), unlike, for example, the nuclear protein Rap1p of *S. cerevisiae*, which is involved in telomere metabolism ([@B21]). Alternatively, G4 RNA structures, which may be formed quickly from short G-rich sequences ([@B36]), may be used in the cell to squelch the activity of Xrn1p/ mXRN1p to achieve overall regulation of the exoribonuclease activity itself.

Implications of the mXRN1p Localization
---------------------------------------

A major distinction between eukaryotic and prokaryotic organisms is the subcellular compartmentalization of the eukaryotic cell in membrane-bound compartments including nucleus, cytoplasm, mitochondria, ER, and Golgi apparatus. In recent years this general organizational picture of the eukaryotic cell was further refined when it was realized that molecular processes like RNA splicing ([@B19]; for review see [@B55]; [@B40]) or DNA replication ([@B44]; for review see [@B55]) are confined to subcompartments within the nucleus. Spatial isolation of lytic activities is of advantage for the cell as demonstrated by the existence of the lysosome compartment. Concentration and confinement of RNA hydrolytic activity in the cytosol is similarly advantageous to minimize a possible interference of the exonuclease with normal cellular processes. The mXRN1p-containing foci are possible sites of RNA turnover in the cytoplasm. Alternatively, the mXRN1p-containing foci may represent storage sites for mXRN1p. However, this is unlikely because the cDNAs do not encode an inactive precursor enzyme but rather an active exoribonuclease (Fig. [7](#F7){ref-type="fig"}). It can be expected that not only RNA turnover but also other molecular processes are confined to specific sites in the eukaryotic cytosol. Because mXRN1p is the first RNA turnover protein to be localized in mammalian cells, colocalization studies with other RNA turnover functions that would support the subcompartmentalization model are unfortunately not possible.

The majority of translatable mRNA in fibroblasts is associated with the cytoskeleton ([@B66]). In developing *Drosophila* embryos and in nerve cells, localized translation of specific mRNAs has been linked to cytoplasmic transport of mRNA along microtubules (for review see St. Johnston, 1995), implying the presence of microtubule-associated proteins that link mRNA to transport along microtubules. The codiscovery of the *S. cerevisiae XRN1* gene as *KEM1* ([@B35]) has suggested that, in addition to being an exoribonuclease, the protein is a microtubule-associated protein ([@B27]). The majority of mouse mXRN1p is localized in foci, which do not contain tubulin. However, the mXRN1p molecules localized more generally in the cytoplasm show general colocalization with the cytoplasmic tubulin network (Fig. [9](#F9){ref-type="fig"} *b*). Moreover, this general sublocalization of mXRN1p but not the foci was abolished when the cells were incubated with a microtubular inhibitor (Fig. [9](#F9){ref-type="fig"} *d*). Cold treatment mimicked this effect (Fig. [9](#F9){ref-type="fig"} *c*), arguing against a drug artifact. This suggests that this subpopulation of mXRN1p molecules is associated with microtubules, possibly relating RNA turnover to the cytoskeleton.
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![Structure and evolutionary conservation of mouse mXRN1p. (*A*). Structural relation of mXRN1p to other yeast and mammalian proteins. The domains of strongest homology are indicated as black boxes (*I--III*). An additional domain (*IV*) with intermittent but highly conserved sequence stretches between mXRN1p, Xrn1p, and ExoIIp is hatched. Numbers above the boxes represent the percentage of amino acid identity to mXRN1p. References to the sequences are found in Materials and Methods. (*B*) Phylogenetic tree of mXRN1p and related proteins. *M.m.*, *M. musculus*; *S.c.*, *S. cerevisiae*; *S.p.*, *S. pombe*; *aa*, amino acids.](JCB.bashkirov2){#F2}

###### 

Complementation of Sporulation Defect in S. cerevisiae xrn1Δ by mXrn1

  Genotype (strain) + plasmid           3-4 Spored asci
  ---------------------------------- -- -----------------
                                        *%*
  Wild type (WDHY187)                   82.0
  *xrn1Δ* (WDHY213)                      7.3
  *xrn1Δ* (WDHY344) + vector            10.0
  *xrn1Δ* (WDHY344) + p*XRN1*           75.3
  *xrn1Δ* (WDHY344) +p*mXrn1*           71.5
  *xrn1Δ* (WDHY344) + p*mXrn1 Δ39*      64.1

Data shown are means of two independent experiments. The percentage of three to four spored asci is the fraction of all cells in the sporulating culture that formed asci containing three or four spores. For the strains, the relevant genotype concerning the *XRN1* gene is given (see Materials and Methods). Vector (YCp50) and the complementation plasmids are described in Materials and Methods. In strain WDHY187 (*a/α XRN1/xrn1Δ::URA3*), the *xrn1* mutation is fully recessive for the sporulation phenotype. Strains were sporulated on plates according to standard procedures and analyzed after 3 d of incubation at 30°C. For each data point, 350--500 cells were analyzed. All strains are isogenic derivatives of *S. cerevisiae* SK-1.  

![Cloning of mouse *mXrn1.* Summary of *mXrn1* cDNA cloning. The reconstructed 5,497-bp cDNA is shown as a thin line. Positions of the translation start (*ATG*) and the stop (*TAA*) codon are indicated. Halfarrows show the position of the PCR primers. The open box represents the PCR-generated probe for the firstround cDNA library screening by DNA hybridization. The cloned cDNA inserts of recombinant phages are presented as thick lines, some of them with hatched boxes indicating the DNA regions used as hybridization probes for cDNA walking. Short poly (T) stretches at the 3′ end of some cDNA derived from the 3′ poly(A) are shown. The 39-bp insert in the cDNA of phages λ10, λ6, λ9, and λ3 at position 4806 is designated by an open triangle.](JCB.bashkirov1){#F1}

![Localization of mouse mXRN1p in cytoplasmic foci. Indirect immunofluorescence of mXRN1p (*red*, *right column*) and superimposed to tubulin immunofluorescence (*green*, *left column*) in the mouse E10 fibroblast cell line. (*a*) Control with preimmune serum (*right column*) and anti-tubulin antibodies (*left column*). (*b--d*) Anti--mouse mXRN1p antibodies (*right column*) and anti-tubulin antibodies (*left column*). *a* and *b* show untreated cells; *c* shows cells kept at 4°C; *d* shows cells treated with benomyl. The position of the nucleus is seen as a negative imprint in the immunofluorescence; note the absence of mXRN1p signal in this region. Bars: 10 μm.](JCB.bashkirov9){#F9}

![Purification and Western blot analysis of mXRN1p. (*A*) Analysis of total protein after induction from strain WDHY131 (*xrn1Δ*) transformed with pGAL*XRN1* (*Xrn1p*; lane *1*, 0.3 μg), with vector (pGAL; lane *2*, 5 μg), with pGAL*mXrn1* (*mXRN1p*; lane *3*, 5 μg), and with pGal*mXrn1Δ39* (*mXRN1Δ39p*; lane *4*, 5 μg) as well as of cytoplasmic extract (90 μg) of adult mouse testis cells (lane *5*). The size difference between the proteins encoded by the m*Xrn1* and *mXrn1Δ39* cDNAs could not have been resolved on this gel system. (*B*) Analysis of protein fractions from mouse mXrn1p purification. 42 μg of fraction I (lanes *2* and *4*) and 0.2 μg of fraction V (lanes *1* and *3*) were analyzed by Coomassie staining (lanes *1* and *2*) and by Western blot analysis (lanes *3* and *4*). Positions of the molecular mass markers are given on the left.](JCB.bashkirov6){#F6}

![Complementation of the slow growth and benomyl hypersensitivity of a *S. cerevisiae xrn1Δ* mutation by mouse *mXrn1.* Strain WDHY131 (*xrn1Δ*) was transformed with either vector (YCp50, row 1), p*XRN1* (row 2), p*mXrn1* (row 3), or p*mXrn1Δ39* (row 4). Serial dilutions of cultures were spotted on medium and incubated as described in Materials and Methods.](JCB.bashkirov3){#F3}

![Complementation of the pre-rRNA processing defect of a *S. cerevisiae xrn1Δ* mutation by mouse *mXrn1.* (*A*) Structure of the 35S pre-rRNA in *S. cerevisiae* with the relevant processing sites of ITS1 ([@B17]; [@B69]). The fragment of ITS1 accumulating in *xrn1* cells but usually degraded in wild-type cells is indicated as a bold line in the blow-up of ITS1. Sequence and position of the oligonucleotide used for Northern blot analysis of total RNA is indicated. (*B*) Complementation of a molecular rRNA turnover defect in *xrn1* cells by *mXrn1.* Northern blot analysis of total RNA from strain WDHY131 (*xrn1Δ*) transformed with either vector (lane *1*), p*XRN1* (lane *2*), p*mXrn1* (lane *3*), or p*mXrn1Δ39* (lane *4*) was done as described ([@B59]). The arrow indicates the location of the ∼200-nt band accumulating in the *xrn1Δ* strain.](JCB.bashkirov4){#F4}

![Complementation of a molecular mRNA turnover defect in *xrn1* cells by mouse *mXrn1.* Equal amounts of poly (A)^+^ (3 μg) and poly(A)^−^ (15 μg) RNA from the four strains described in Fig. [3](#F3){ref-type="fig"} were fractionated on a gel and analyzed by hybridization with specific probes as described ([@B26]). Given are the relative amounts of rRNA loaded as quantified from scanning of the ethidium bromide--stained gel. The distribution of the specific mRNAs between the poly(A)^+^ and poly(A)^−^ fractions were quantified by PhosphorImager.](JCB.bashkirov5){#F5}

###### 

Characterization of mXRN1p. (*A*) Time course of RNA hydrolysis by mXRN1p. Shown are the means ± SD of three independent experiments. (*B*) Binding to G4 tetraplex RNA and DNA substrates. Tetraplex RNA (rGL\[G4\], *solid circle*), tetraplex DNA (GL\[G4\], *open circle*), or a monomeric single-stranded RNA oligonucleotide of the same sequence (rGL\[SS\], *solid square*) were used in binding assays as described in Materials and Methods. The amount of free nucleic acid was plotted against mXRN1p concentration. Shown are the means ± SD of three independent experiments. For some values the error bars do not exceed the limits of symbol. (*C*) Hydrolysis of G4 tetraplex substrates. The cleavage activity of mXRN1p for the substrates used in *B*---tetraplex RNA (rGL\[G4\], *solid circle*), tetraplex DNA (GL\[G4\], *open circle*), monomeric single-stranded RNA oligonucleotide of the same sequence (rGL\[SS\], *solid square*), and monomeric single-stranded DNA oligonucleotide of the same sequence (GL\[SS\], *open square*)---was determined and is expressed as fmoles of cleaved input substrate. Time courses were from 0 to 30 min. 0 min was defined as the fmoles of cleaved substrate before addition of enzyme because the reaction was too fast to sample after addition of enzyme. Shown are the means ± SD of three independent determinations. For some values the error bars do not exceed the limits of symbol. (*D*) Protein titration of mXRN1p for hydrolysis of G4 tetraplex substrates. The cleavage activity of mXRN1p for two substrates used in *B*---tetraplex DNA (GL\[G4\], *left*) and tetraplex RNA (rGL\[G4\], *right*), 15 fmol each---was determined in reactions containing 0--62.5 fmol of mXRN1p for 15 min at 37°C (lanes *1* and *6*, 0 fmol; lanes *2* and *7*, 0.5 fmol; lanes *3* and *8*, 2.5 fmol; lanes *4* and *9*, 12.5 fmol; lanes *5* and *10*, 62.5 fmol). Shown is the autoradiograph of a gel resolving the substrate (*GL\[G4\]* or *rGL\[G4\]*), the enzyme--substrate complex (*C*), and the cleavage product (*CP*). Monomeric substrate (*GL\[ss\]* or *rGL\[ss\]*) is also present in minor quantities because of spontaneous decomposition of the substrate.
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![mXRN1p is responsible for G4 tetraplex--specific binding. mXrn1p was immunoprecipitated using anti-Xrn1p mAb H8, which cross-reacts with mXrn1p (lanes *1* and *2*), with control antibody B4, which does not recognize mXRN1p (lanes *3* and *4*) or with a control lacking secondary antibody (lanes *5* and *6*) as described in Materials and Methods. 5 μl of the precipitate was analyzed by immunoblotting (*A*) using a rat anti--mXRN1p antibody. Positions of the molecular mass markers are given on the right. In *B*, 5 μl of the precipitate was analyzed for complex formation with the G4 tetraplex DNA substrate (GL\[G4\]). *C* denotes the position of the complex and G4 denotes the position of the free substrate.](JCB.bashkirov8){#F8}
